Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 78
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Taipei (ESPB group, Control group)

Recruiting
  • Hepatocellular Carcinoma
  • ESPB group
  • Control group
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 13, 2021

Hepatocellular Carcinoma Registry in Asia

Completed
  • Hepatocellular Carcinoma
    • Camperdown, New South Wales, Australia
    • +33 more
    Feb 18, 2021

    Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC Trial in Worldwide (Ramucirumab, MEDI4736)

    Completed
    • Gastric Cancer
    • +3 more
    • Santa Monica, California
    • +27 more
    Jan 18, 2021

    Hepatocellular Carcinoma Trial in Worldwide (PDR001, Sorafenib)

    Completed
    • Hepatocellular Carcinoma
    • Detroit, Michigan
    • +8 more
    Dec 16, 2020

    Hepatocellular Carcinoma Trial in Taipei (telephone consultations about psychoeducation program)

    Completed
    • Hepatocellular Carcinoma
    • telephone consultations about psychoeducation program
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 12, 2020

    Hepatocellular Carcinoma, Metastatic Liver Cancers Trial in Taipei (Irreversible Electroporation (IRE) System)

    Completed
    • Hepatocellular Carcinoma
    • Metastatic Liver Cancers
    • Irreversible Electroporation (IRE) System
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jul 2, 2020

    HepatoCellular Carcinoma, Liver Cancer Trial in Taipei (IKC (Immune Killer Cells), TACE (Transcatheter Arterial

    Unknown status
    • HepatoCellular Carcinoma
    • Liver Cancer
    • IKC (Immune Killer Cells)
    • TACE (Transcatheter Arterial Chemoembolization)
    • Taipei, Taiwan
      Tri Service General Hospital
    Apr 14, 2020

    Liver Fibrosis, HEPATITIS B CHRONIC, Hepatocellular Carcinoma Trial in Taipei (DCB-BO1202, Placebo, DCB-BO1202+Placebo)

    Withdrawn
    • Liver Fibrosis
    • +2 more
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jan 10, 2020

    Hepatocellular Carcinoma Trial in Worldwide (drug, other, procedure)

    Completed
    • Hepatocellular Carcinoma
    • Los Angeles, California
    • +93 more
    Nov 26, 2019

    Hepatocellular Carcinoma Trial in Worldwide (ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol), Placebo, Best

    Completed
    • Hepatocellular Carcinoma
    • ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol)
    • +2 more
    • Birmingham, Alabama
    • +72 more
    Aug 27, 2019

    Gastroesophageal Varices Hemorrhage, Hepatocellular Carcinoma Trial in Taipei (propranolol)

    Unknown status
    • Gastroesophageal Varices Hemorrhage
    • Hepatocellular Carcinoma
    • Taipei, Ming-Chih Hou, MD, Taiwan
      Veteran General Hospital-Taipei
    Aug 29, 2019

    Bleeding Esophageal Varices, Hepatocellular Carcinoma Trial in Taipei (Propranolol, Esophageal variceal ligation)

    Recruiting
    • Bleeding Esophageal Varices
    • Hepatocellular Carcinoma
    • Taipei, Taiwan
      Taipei Veterans General Hospital
    Aug 29, 2019

    Hepatocellular Carcinoma Trial in Japan, Korea, Republic of, Taiwan (Orantinib (TSU-68), Placebo)

    Terminated
    Has Results
    • Hepatocellular Carcinoma
    • Orantinib (TSU-68)
    • Placebo
    • Osaka-sayama, Osaka, Japan
    • +5 more
    Aug 5, 2019

    Metastatic Breast Cancer, Advanced Breast Cancer, Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (sunitinib)

    Completed
    Has Results
    • Metastatic Breast Cancer
    • +11 more
    • Atlanta, Georgia
    • +112 more
    Jun 20, 2019

    Hepatocellular Carcinoma Trial in China, Taiwan (Lipotecan)

    Terminated
    • Hepatocellular Carcinoma
    • Beijin, China
    • +11 more
    Feb 23, 2019

    Hepatocellular Carcinoma Trial in Worldwide (BMS-986183, Nivolumab)

    Terminated
    Has Results
    • Hepatocellular Carcinoma
    • BMS-986183
    • Nivolumab
    • Ottawa, Ontario, Canada
    • +3 more
    Jan 7, 2019

    Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (TKM-080301)

    Completed
    • Hepatocellular Carcinoma
    • +3 more
    • Tucson, Arizona
    • +14 more
    Jan 14, 2019

    Hepatocellular Carcinoma Trial in Worldwide (Axitinib (AG-013736), Best Supportive Care, Placebo)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Axitinib (AG-013736)
    • +2 more
    • Berkeley, California
    • +76 more
    Dec 20, 2018

    HepatoCellular Carcinoma, Portal Vein Tumor Thrombosis Trial in Taichung, Taipei (Lipotecan)

    Terminated
    • HepatoCellular Carcinoma
    • Portal Vein Tumor Thrombosis
    • Taichung, Taiwan
    • +3 more
    Nov 4, 2018

    Hepatocellular Carcinoma Trial in Taipei

    Unknown status
    • Hepatocellular Carcinoma
      • Taipei, Taiwan
        Taipei Veterans General Hospital
      Sep 20, 2017

      Hepatocellular Carcinoma Trial in Taipei

      Unknown status
      • Hepatocellular Carcinoma
        • Taipei, Taiwan
          Taipei Veterans General Hospital
        Sep 4, 2017

        Specific Markers and Their Prognostic Significance in

        Completed
        • Hepatocellular Carcinoma
        • Retrospective analysis of already archived samples
        • Taipei, Taiwan
        • +2 more
        May 25, 2017

        Integrated MRI/PET in Patients With Hepatocellular Carcinoma

        Unknown status
        • Hepatocellular Carcinoma
        • The imaging biomarkers determined by MR-PET
        • Taipei, Taiwan
          National Taiwan University Hospital
        May 14, 2017

        Post-operative HBV-related Hepatocellular Carcinoma

        Terminated
        • Hepatocellular Carcinoma
        • Adefovir Dipivoxil and Lamivudine
        • Kaohsiung, Taiwan
        • +7 more
        Apr 26, 2017

        Hepatocellular Carcinoma Trial in Worldwide (ThermoDox, 5% Dextrose Solution)

        Completed
        Has Results
        • Hepatocellular Carcinoma
        • Los Angeles, California
        • +78 more
        Mar 24, 2017